骨髓介质干细胞外体抑制JAK/STAT信号通路在急性髓性白血病在体外
Sahar Jalilivand1, Maryam Nabigol1, Mehdi Bakhtiyaridovvombaygi2,3
1Department of Laboratory Hematology and Blood Bank, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Blood research
|December 20, 2024
概括
骨髓介质干细胞 (BM-MSC) 外基因组显著降低了急性髓性白血病 (AML) 细胞中的Janus激酶/信号转换器和转录激活器 (JAK/STAT) 基因的调节. 这表明BM-MSC外体可能为AML治疗提供一种新的治疗策略.
科学领域:
- 生物医学研究的研究.
- 癌症生物学 癌症生物学
- 干细胞疗法是一种干细胞疗法.
背景情况:
- 由于耐火性疾病和复发,急性髓性白血病 (AML) 仍然具有挑战性.
- 介酶干细胞 (MSC) 和它们的外体显示出治疗潜力.
- 针对性治疗对于改善AML治疗结果至关重要.
研究的目的:
- 为了研究骨髓介质干细胞 (BM-MSC) 异构体对雅努斯酶/信号转换器和转录激活器 (JAK/STAT) 在AML中的信号传递的影响.
- 评估BM-MSC外体作为AML的治疗剂的潜力.
主要方法:
- 外体从BM-MSC中分离出来,并使用电子显微镜,动态光散射和流细胞计进行了表征.
- HL-60白血病细胞与BM-MSC外体共同培养.
- 用定量实时PCR (qRT-PCR) 分析了JAK2,STAT3和STAT5的基因表达.
主要成果:
- 证实BM-MSC外体是具有特定表面标记 (CD9,CD63,CD81) 和大小 (80-100 nm) 的纳米粒子.
- 用BM-MSC外体的治疗导致HL-60细胞中JAK2,STAT3和STAT5基因表达的显著下调.
结论:
- JAK/STAT信号传递与AML细胞存活有关.
- BM-MSC外基因组有效降低白血病细胞中关键的JAK/STAT通路基因的调节.
- BM-MSC外基因组代表了开发新型AML治疗策略的有希望的途径.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


